Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

Authors:

Abstract
No abstract available
Funding Information
  • Fondazione Umberto Veronesi
  • National Institute for Health Research
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Lundbeck

This publication has 102 references indexed in Scilit: